Skip to main content
Journal of Clinical Laboratory Analysis logoLink to Journal of Clinical Laboratory Analysis
. 2012 May 24;26(3):125–129. doi: 10.1002/jcla.21497

Optical and Mechanical Clot Detection Methodologies: A Comparison Study for Routine Coagulation Testing

Nilgun Tekkesin 1,, Cumhur Kılınc 2
PMCID: PMC6807321  PMID: 22628225

Abstract

Background

Automated coagulation analyzers are preferred to meet increasing coagulation test volume. Two distinct technological families exist based on optical and mechanical clot detection methodologies. Which one is superior to the other is still a conflict and needs new studies.

Methods

We have compared prothrombin and activated partial thromboplastin results obtained with mechanical method with those obtained by photo‐optical method used routinely in our specialized laboratory.

Results

The instrumental results showed good precision ranging between 0.7% and 1.8% coefficient of variation. Statistical analysis demonstrated an excellent correlation between the photo‐optical and mechanical analyzers for PT (R2 0.97), and aPTT (R2 0.85).

Conclusion

Correlation between the two clot‐detection systems was maintained even when measuring turbid samples (R 2 ≥ 0.97 for two tests). J. Clin. Lab. Anal. 26:125‐129, 2012. © 2012 Wiley Periodicals, Inc.

Keywords: blood coagulation, factors, partial thromboplastin time, prothrombin time, clot detection, mechanical detection, optical detection

INTRODUCTION

Coagulation analyzers run the gamut of options, from automated instruments to manual devices, from high‐volume processing to low‐volume analysis, and from a wide selection of assays to a small, core group of tests. Because of the increasing demand for high‐volume, routine coagulation testing, automated coagulation analyzers have become more popular over the last decade. Examples of automated instrument include the Coag‐A‐Mate MTX‐2 (MTX II) and AMAX 200 1, 2. TrinityBiotech's MTX II (TrinityBiotech, Berkeley Heights, NJ) is a medium‐volume analyzer with many of the features of high‐volume systems. Using photo‐optical detection with a 405‐nm halogen light source, the compact, bench top analyzer performs many tests besides basal coagulation tests, including: prothrombin time (PT) and activated partial thromboplastin time (aPTT). AMAX 200 (TrinityBiotech) can measure clot formation in both photo‐optical and mechanical modes. It has been widely held that mechanical clot detection is unaffected by turbid samples and, hence, is superior to photo‐optical detection, which, in contrast, may be affected by turbid samples 4, 5, 6, 7. This has led to the belief that mechanical detection provides a true clotting time (CT) determination for coagulation testing. Some studies have suggested that optical and mechanical detection methods are equivalent in terms of correlation, accuracy, and precision for coagulation testing, and that both methods are unaffected by sample turbidity 8, 9, 10. Other studies have suggested that optical detection is superior to mechanical detection 8, 9, 10, such as in a clinically important case of dysfibrinogenemia caused by a familial mutation 11 and a biphasic waveform that indicated a suspicious sepsis patient 10. Consequently, the advantage of one detection method over the other remains unknown. In the present study, we set out to obtain new information on the comparability of core haemostasis assays in routine patient samples in a high‐volume hospital setting. The PT and aPTT tests were performed in both the optical (MTX II) and mechanical (AMAX 200) modes and the results were compared using linear regression. Within‐run, total precision and reference intervals according to relevant NCCLS guidelines were also determined for each assay on the MTX II and AMAX 200 12, 13, 14, 15, 16, 17.

MATERIALS AND METHODS

The randomly‐selected patient samples obtained from the normal course of the clinical laboratory's daily routine were prospectively collected into a tube (Becton Dickinson light blue tube) containing 3.2% sodium citrate and tested for PT and aPTT. MTX II, an automated photo‐optical coagulation analyzer, was one of the test methods. The optical measurement was based on the change of physical aspect of the plasma (because the fibrin polymer will catch some proteins and reduce the opacity of the sample). When measured optically, a significant difference of absorbancy of the sample was observed after the clot formation. The AMAX 200, an automated photo‐mechanical coagulation analyzer, served as the comparative method. The mechanical measurement was based on the true clot detection; the analyzer is using the ball to detect the presence of the clot in the reaction cuvette. Both systems are distributed by TrinityBiotech, Berkeley Heights, New Jersey, USA. To reduce variability, only TrinityBiotech reagents, controls, calibrators, and consumables were used on the two test systems. A total of 424 patient samples were included in the study during a period of 15 days. In cases where the sample was hemolyzed or icteric or lipaemic, the sample's physical aspect before the test was changed. The physical aspect of each sample was done and turbid or hemolyzed samples were classified as inappropriate.

Plasma from 25 normal healthy individuals was assayed to obtain the geometric means and reference ranges for PT and aPTT for both the MTX II and AMAX 200 instruments, respectively. Daily, weekly, and monthly quality control and maintenance were performed following the manufacturers’ recommended procedures.

STATISTICAL METHODS

Mean, standard deviation (SD) and percentage coefficient of variation were calculated for each assay. Calculations were performed by linear regression analysis with an R 2 > 0.95 predetermined as an acceptable correlation. Statistical significance was defined by a hypothesis test yielding a P‐value of less than 0.05.

RESULTS

Reference ranges and precision

Plasma samples from 25 healthy normal donors yielded the following reference ranges: for PT, 10.5–12.3 s and 11.3–13.4 s, respectively, for MTX II and AMAX 200; for aPTT, 24.5–33.9 s and 25.5–35.8 s, respectively, for MTX II and AMAX 200. Both normal and abnormal controls demonstrated excellent interassay and intraassay precisions for two assays well within manufacturer's specifications.

Sample summary

We randomly collected 424 clinical samples from a routine high‐volume clinical laboratory. As shown in Table 1, among the 424 samples, 420 (99%) had PT results, and 388 (91.5%) had aPTT results. Thirty‐two samples had visually observed interferences due to haemolysis or lipemia.

Table 1.

Intraassay Precision of MTX IIand AMAX 200 in Normal and Abnormal Control Products (n = 20)

Normal control Abnormal control
PT(s) aPTT(s) PT(s) aPTT(s)
MTX II AMAX 200 MTX II AMAX 200 MTX II AMAX 200 MTX II AMAX 200
Mean 11.3 12.1 26.2 25.9 38.3 41.8 537 63.2
SD 0.1 0.1 0.1 0.1 0.3 0.8 1.2 0.7
CV (%) 0.6 0.9 0.5 0.5 0.7 1.8 1.8 1.2

Correlation between photo‐optical and electromechanical clot detection

Correlation was determined using more than 400 clinical samples over a 15‐day time period. Statistical analysis demonstrated an excellent correlation between the photo‐optical and mechanical analyzers for PT (R 20.97), and aPTT (R20.85) Table 1; Figs 1, 2.

Figure 1.

Figure 1

Correlation of TriniClot PT HTF performed on MTX IIand AMAX 200 (n = 420).

Figure 2.

Figure 2

Correlation of TriniClot aPTT S performed on MTX II and AMAX 200 (n = 407).

“No clot” samples

For two assays examined, any result that showed “no clot” was either printed as “no clot found” (MTX II), or “no coagulation” or “analysis time over” (AMAX 200). Although a total of 424 samples were tested, some were not included in the data set due to inappropriate volume for one of the two methods. For PT, among the 412 samples tested, one sample yielded a “no clot” error on MTX II due to the fact that the upper limit of the PT setting is 100 s on MTX II, whereas it produced results by AMAX 200 (130.4 s). For aPTT, 388 samples were tested, with five samples showing “no clot” on MTX II, whereas they provided results with AMAX 200. As shown in Table 4, in no case did MTX II provide a PT or an aPTT result, whereas AMAX 200 yielded “no coagulation.”

Table 4.

Number of “No Clot” Sample Results by Test Method

method Test Total sample sizea No clot on MTX II and reported result on AMAX 200 Excluded for hemolysis, lipemia, or icterus
PT (s) 412 1 (0.2%) 15 (0.9%)
aPTT (s) 388 5 (1.2%) 17 (4.38%)
a

Varying sample sizes were due to lack of clot formation in certain assays.

Table 2.

Interassay Precision of MTX IIand AMAX 200 in Normal and Abnormal Control Products (n = 30)

Normal control Abnormal control
PT(s) aPTT(s) PT(s) aPTT(s)
MTX II AMAX 200 MTX II AMAX 200 MTX II AMAX 200 MTX II AMAX 200
Mean 10.4 9.3 28.2 31.1 45.9 49.5 65.5 75.2
SD 0.1 0.2 0.4 0.6 2.0 1.5 2.5 1.5
CV (%) 1.4 1.8 1.5 1.9 4.3 3.0 3.8 2.0

Table 3.

Reference Values. 95% Confidence Intervals are Shown in Parentheses. Reference Values are for 25 Healthy Volunteers

Median (ranges) Reference value, mean (SD)
MTX II AMAX 200 MTX II AMAX 200
PT (s) 9.8 (6.6–100.0) 10.6 (8.0–104.8) 10.5–12.3 11.3–13.4
aPTT (s) 28.6 (17.7–199.2) 29.4 (20.8–208.2) 24.5–33.9 25.5–35.8

Samples with visually observed interferences

A total of 32 samples (2.8% overall) with visually observed interferences were identified and tested on MTX II and AMAX 200 for PT and aPTT. Further analysis of the subgroup of turbid samples indicated that the correlation remained strong between the two detection methods (PT (R 20.97), and aPTT (R 20.98)) (Table 6).

Table 6.

Correlation Analysis for 32 Turbid Samples Tested on MTX IIand AMAX200

Correlation (r) Slope (95% CI) Intercept (95% CI) Comparison (P)
PT (s) 0.97 0.96 0.85 <0.001
APTT (s) 0.98 0.96 0.89 <0.001

DISCUSSION

Our study was designed to obtain new information on the comparability of mechanical and photo‐optical detection methods in determining CT for a given sample. Current results were similar to other studies that photo‐optical and mechanical clot detections are satisfactory for the basal coagulation not only in samples with normal optical quality but also in optically abnormal specimens (e.g., in lipemia, hyperbilirubinemia, and haemolysis) 18. Photo‐optical and mechanical detection for routine coagulation analysis (PT and aPTT) were highly correlated in 412 samples tested over a 15‐day time period in a high‐volume clinical laboratory (Table 5). Concerning intra‐ and interassay precision, CVs were below 5% in both assays. We also observed that the two methods generated similar reference intervals and SDs. A small percentage of normal results as not measured by MTX II were reported on AMAX 200 (0.2 and 1.2 PT and aPTT, respectively) (Table 4). In clinical practice, proper reference ranges for PT and aPTT are typically established with a local normal donor group. In establishing such reference ranges, certain diagnostic criteria must be met, including sensitivity for various factor assays related to the “intrinsic” and “extrinsic” pathways to assure adequate differentiation of normal coagulation from underlying factor deficiencies when obtaining an abnormal CT 3.

Table 5.

Correlation Analysis for All Samples Performed on MTX IIand AMAX 200

Correlation (r) Slope (95% CI) Intercept (95% CI) Comparison (P)
PT (s) 0.97 1.033 (−) 0.43 <0.01
APTT (s) 0.85 0.96 (−) 0.87 <0.01

Our results indicate that turbidity has no significant effect on photo‐optical detection as compared with mechanical detection. We have shown equivalent results between the two systems with 32 turbid samples. The issue of sample integrity for coagulation testing continues to be a growing concern in clinical laboratory practice due to preanalytical error caused by the blood collection personnel with varied backgrounds and experience. Particularly, haemolysis during the blood collection process must be identified and those samples replaced with nonhemolyzed samples when possible 19, 20.

Regarding setting criteria to perform alternative procedures, our study demonstrated equivalency between photo‐optical and mechanical detection methods. It is therefore reasonable that one method may be used for the other when considering repeat testing.

CONCLUSION

All data obtained during this study indicate that the patient results obtained by the photo‐optical detection system are as reliable and statistically equivalent as those obtained using the mechanical detection system. Most notably, we also found that when testing suboptimal samples (i.e., hyperbilirubinemia, lipemia, etc.) the photo‐optical and mechanical detection methods are statistically equivalent.

REFERENCES

  • 1. Cugno MM, Chantarangkul V, Tripodi A, Mannucci PM. Assessment of a new instrument (Coag‐A‐Mate X2) for performing global clotting tests and specific factor assays. Clin Lab Haematol 1985;7:75–81. [DOI] [PubMed] [Google Scholar]
  • 2. Flanders MM, Crist R, Safapour S, Rodgers GM. Evaluation and performance characteristics of STA‐R coagulation analyzer. Clin Chem 2002;48:1622–1624. [PubMed] [Google Scholar]
  • 3. NCCLS . One stage prothrombin time (PT) test and activated partial thromboplastin time (APTT) test; approved guideline. NCCLS H47‐A 16:4, Vol. 28:7–8. [Google Scholar]
  • 4. Quehenberger P, Kapiotis S, Handler S, Ruzicka K, Speiser W. Evaluation of the automated coagulation analyzer SYSMEX CA 6000. Thromb Res 1999;96:65–71. [DOI] [PubMed] [Google Scholar]
  • 5. Dorn‐Beineke A, Demfle CE, Bertsch T, Wisser H. Evaluation of the automated coagulation analyzer Sysmex CA‐7000. Thromb Res 2005;116:171–179. [DOI] [PubMed] [Google Scholar]
  • 6. Fischer F, Appert‐Flory A, Jambou D, Toulon P. Evaluation of the automated coagulation analyzer Sysmex CA‐7000. Thromb Res 2006;117:721–729. [DOI] [PubMed] [Google Scholar]
  • 7. D'Angelo A, Seveso MP, D'Angelo SV, Gilardoni F, Macagni A, Manotti C, Bonini P. Comparison of two automated coagulometers and the manual tilttube method for the determination of prothrombin time. Am J Clin Pathol 1989;92:321–328. [DOI] [PubMed] [Google Scholar]
  • 8. Fernandes B, Giles A. An abnormal activated partial thromboplastin time clotting waveform is associated with high mortality and a procoagulant state. Lab Hematol 2003;9:138–142. [PubMed] [Google Scholar]
  • 9. Nesheim M, Samis J, Walker J, Becker L, Brufatto N, Fischer T, et al. Lipoprotein‐complexed C‐reactive protein and the biphasic transmittance waveform in critically ill patients. Blood Rev 2002;16(Suppl 1):S15–S22. [PubMed] [Google Scholar]
  • 10. Toh CH, Ticknor LO, Downey C, Giles AR, Paton RC, Wenstone R. Early identification of sepsis and mortality risks through simple, rapid clotwaveform analysis. Implications of lipoprotein‐complexed Creactive protein formation. Intensive Care Med 2003;29:55–61. [DOI] [PubMed] [Google Scholar]
  • 11. Lefkowitz J, DeBoom T, Weller A, Clarke S, Lavrinets D. Fibrinogen Longmont: a dysfibrinogenemia that causes prolonged clot‐based test results only when using an optical detection method. Am J Hematol 2000;63:149–155. [DOI] [PubMed] [Google Scholar]
  • 12. National Committee for Clinical Laboratory Standards . Method comparison and bias estimation using patient samples: approved guidelines. NCCLS Document EP9‐A 1998; Vol. 15, No. 17 NCCLS Wayne, PA. [Google Scholar]
  • 13. National Committee for Clinical Laboratory Standards . Evaluation of the linearity of quantitative analytical methods. NCCLS Document EP6‐P 1986; Vol. 6, No. 18 NCCLS Villanova, PA. [Google Scholar]
  • 14. National Committee for Clinical Laboratory Standards . Evaluation of precision performance of clinical chemistry devices: approved guideline. NCCLS Document EP5‐A 1999; Vol. 19, No. 2 NCCLS Wayne, PA. [Google Scholar]
  • 15. National Committee for Clinical Laboratory Standards . Assessment of clinical sensitivity/specificity of laboratory tests. NCCLS Document GP10‐P 1987; Vol. 7, No. 6 NCCLS Wayne, PA. [Google Scholar]
  • 16. National Committee for Clinical Laboratory Standards . Collection, transport, and processing of blood specimens for coagulation testing and general performance of coagulation assays: approved guideline. NCCLS Document H21‐A3 1998; Vol. 18, No. 20 NCCLS Wayne, PA. [Google Scholar]
  • 17. National Committee for Clinical Laboratory Standards . How to define, determine, and utilize reference intervals in the clinical laboratory: approved guideline. NCCLS Document C28‐A 1995; Vol. 15, No. 4 NCCLS Villanova, PA. [Google Scholar]
  • 18. Baia B, Christieb DJ, Gormanb RT and Wua JR. Comparison of optical and mechanical clot detection for routine coagulation testing in a large volume clinical laboratory. Blood Coagul Fibrin 2008;19:569–576. [DOI] [PubMed] [Google Scholar]
  • 19. College of American Pathologists (CAP) Laboratory Accreditation Program (LAP) Checklist . Hematology – coagulation checklist: 12/29/2004 ed. Northfield: College of American Pathologists; 2004. [Google Scholar]
  • 20. Lippi G, Montagnana M, Salvagno GL, Guidi GC. Interference of blood cell lysis on routine coagulation testing. Arch Pathol Lab Med 2006;130:181–184. [DOI] [PubMed] [Google Scholar]

Articles from Journal of Clinical Laboratory Analysis are provided here courtesy of Wiley

RESOURCES